ScoreComparison
Why is Biofrontera, Inc. ?
1
Poor Management Efficiency with a low ROE of 0%
- The company has reported losses. Due to this company has reported negative ROE
2
Positive results in Mar 26
- OPERATING CASH FLOW(Y) Highest at USD -9.31 MM
- NET SALES(HY) At USD 27.18 MM has Grown at 28.55%
- NET PROFIT(HY) Higher at USD 4.42 MM
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 55.99%, its profits have risen by 40.1%
4
High Institutional Holdings at 22.34%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
- Their stake has increased by 0.74% over the previous quarter.
5
Market Beating performance in long term as well as near term
- Along with generating 55.99% returns in the last 1 year, the stock has outperformed S&P 500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Biofrontera, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Biofrontera, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Biofrontera, Inc.
55.99%
0.08
81.06%
S&P 500
20.78%
1.56
13.28%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
32.33%
EBIT Growth (5y)
-7.25%
EBIT to Interest (avg)
-16.57
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
2.85
Sales to Capital Employed (avg)
12.07
Tax Ratio
0.17%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
22.34%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.91
EV to EBIT
-0.71
EV to EBITDA
-0.77
EV to Capital Employed
0.90
EV to Sales
0.19
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-126.07%
ROE (Latest)
-109.12%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend15What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD -9.31 MM
NET SALES(HY)
At USD 27.18 MM has Grown at 28.55%
NET PROFIT(HY)
Higher at USD 4.42 MM
RAW MATERIAL COST(Y)
Fallen by -48.36% (YoY
DEBTORS TURNOVER RATIO(HY)
Highest at 10.92 times
-6What is not working for the Company
INTEREST(HY)
At USD 0.24 MM has Grown at 40%
INVENTORY TURNOVER RATIO(HY)
Lowest at 1.68 times
Here's what is working for Biofrontera, Inc.
Net Profit
At USD 4.42 MM has Grown at 168.01%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very positive
Net Profit (USD MM)
Operating Cash Flow
Highest at USD -9.31 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Net Sales
At USD 27.18 MM has Grown at 28.55%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Net Profit
Higher at USD 4.42 MM
than preceding 12 month period ended Mar 2026MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (USD MM)
Debtors Turnover Ratio
Highest at 10.92 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by -48.36% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Biofrontera, Inc.
Interest
At USD 0.24 MM has Grown at 40%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
Inventory Turnover Ratio
Lowest at 1.68 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
